Micron's NAND Share Gains Fail to Counter Peak-Cycle Valuation Concerns

What happened

Micron's stock has come under selling pressure despite a Barron's article arguing the market is overlooking the company's increasing share of the NAND flash memory market. The article highlights NAND market share gains as a positive, but it does not address the core drivers that dominate Micron's current earnings, which are AI-related DRAM and high-bandwidth memory (HBM). According to the latest DeepValue report, NAND represents only about 24% of revenue, and strategic customer agreements already cover roughly one-third of NAND volume with price ceilings that limit upside. The stock's decline is more likely tied to broader concerns about peak memory pricing and valuation, as the report noted that at $877.6 the stock already discounts peak scarcity economics and clean HBM4E execution. While NAND share gains are a modest positive, they do not materially change the investment thesis, which remains contingent on DRAM inventory levels, strategic agreement expansion, and HBM execution.

Implication

The NAND market share increase does not alter the fundamental risk-reward for Micron, as the stock continues to trade above the report's attractive entry level. Investors should focus on the upcoming fiscal Q4 results, which must meet or exceed the guided $50 billion revenue and 86% gross margin to support the current price. More importantly, watch for details on strategic customer agreements; if new agreements shift toward market-based pricing rather than floor/ceiling structures, the thesis weakens. The report's bear case hinges on DRAM inventory rising above 130 days or industry capacity shifting back to conventional DRAM, and NAND share gains do not address this risk. Therefore, hold existing positions but avoid adding; the next six months will clarify whether the scarcity economics justifying current valuations persist.

Thesis delta

The Barron's article highlights a new data point—NAND market share gains—but this was not a focus of the original thesis, which centered on DRAM and HBM demand, contract structures, and inventory levels. The information is incremental and does not change the overall assessment; the stock remains a WAIT with an attractive entry at $760. No material shift in the investment thesis is warranted based on this news alone.